Not exact matches
Patients in danger of dying from uncontrollable
bacterial infections could find new allies: killer viruses known as
phages.
«We can sequence a
phage quickly and say, this is the exact DNA sequence we want,» says Paul Grint, CEO of AmpliPhi Biosciences, a startup that is concocting combinations of
phages in advance to treat
bacterial infections like Staphylococcus aureus.
Researchers are training the system to learn how to pick out
phages that can infect a specific
bacterial strain.
Phages identify and grab bacteria using proteins on their leglike tail fibers, which form a strong bond with compounds on the
bacterial cell surface.
Fischetti and his colleagues used a
phage - encoded molecule to identify a
bacterial target enzyme called 2 - epimerase, which is used by Bacillus anthracis to synthesize an essential cell wall structure.
To test the viability of these sequences, the investigators selected one of the 181
bacterial genomes, and found that they were able to induce one of several
phage sequences within that genome to reproduce.
The tailspike protein (TSP) of Salmonella typhimurium
phage P22 is a part of the apparatus by which the
phage attaches to the
bacterial host and hydrolyzes the O antigen.
When levels of arbitrium build up — after a large number of cells have died —
phages stop killing off the remaining bacteria and retreat to lie dormant in
bacterial genomes instead.
Phage therapy, which exploits the ability of certain viruses to infect and replicate within bacteria, shows promise for treating antibiotic - resistant
bacterial infections.
«
Phage treatment was effective in inhibiting
bacterial growth in food, while the number of
phages in the food grew, indicating that
phages infect bacteria and grow in them also when refrigerated,» says Skurnik.
In this case as well, the
phages effectively inhibited
bacterial growth.
Since
phages have evolved with their
bacterial targets for billions of years, they could solve the problem of antibiotic resistance for good; the downside is that each
bacterial strain requires its own tailored
phage cocktail, so it could be many years before doctors have a suitably broad range of
phages at their disposal.
Research focused on the utilisation of viruses that infect and kill bacteria, known as bacteriophages or
phages, in preventing infectious diseases has gained new traction after
bacterial resistance to antibiotics has become a global problem.
Further down the line, he says, this could be harnessed for personal
phage therapy, where specially designed bacteriophages can be inserted into the gut to kill or boost certain
bacterial populations that have gone awry.
Once the
bacterial hosts are gone, the
phages will also die, Leverentz explains.
They found that the
phages from antibiotic - treated mice carried significantly higher numbers of
bacterial drug - resistance genes than they would have carried by chance.
She explained that
phages outnumber their
bacterial prey by a factor of 10 to 1, and that they have been proposed as the agents of change in recipients of faecal microbiota transplantations used to treat resistant or recurring bowel disease.
Earlier this year, a team led by microbiologist Ry Young of Texas A&M University in College Station showed that an especially tiny type of
phage blocks a
bacterial enzyme that builds cell walls.
The
phages infiltrate
bacterial cells, where they commandeer the host machinery to make thousands of new
phages; then they escape through the
bacterial cell wall — killing the host — and spread to infect their next victims.
Also,
phages evolve with the host and have the potential to overcome
bacterial resistance, said coauthor Jochen Klumpp of the Institute of Food, Nutrition and Health, ETH Zurich.
Oral
phage therapy has demonstrated to be a feasible and effective tool in the control of infections caused by different
bacterial pathogens.
Rapidly changing viromes would have signaled an «arms race» in which threatened bacteria were adapting to survive
phage attacks, and the
phages were adapting to avoid
bacterial defenses.
Based on the genetic blueprint, these
bacterial cells then produce all the components of the desired
phage and ensure that the virus particles are assembled correctly.
This enables scientists to genetically modify
phage genomes systematically, provide them with additional functionality, and finally reactivate them in a
bacterial «surrogate» — a cell - wall deficient Listeria cell, or L - form.
Phages, shown here surrounding and attacking a
bacterial cell, are part of a newly discovered type of immunity that protects mucus - covered human tissue from
bacterial infection.
Phage elements, including those not integrated into chromosomes, are part of a
bacterial system for regulating genes.
Their activity outside the chromosomes has been poorly studied; most research has focused on
phages integrated into
bacterial chromosomes.
For instance, some of these
phage elements can activate or silence
bacterial genes by moving into or out of the chromosome.
For example, specially targeted
phages have been suggested as a possible therapy for conditions like cystic fibrosis, which is caused by frequent
bacterial lung infections.
These
phages and plasmids can easily move between
bacterial cells, and scientists have known for some time that, as a result, these so - called mobile genetic elements can play important roles in virulence and antibiotic resistance.
A new technique allows researchers to examine pieces of often - overlooked DNA outside
bacterial chromosomes, including viruses known as
phages (as shown above), which may play a role in disease.
The impact of the microbiota on bone marrow transplantation in mice, differences in
phage infection efficiency in nearly identical hosts,
bacterial diversity of Brazilian artisanal cheese.
If you can help identify some
phages that are active against his (
bacterial) isolate, I'll give it a whirl.»
Plasmids survive despite their cost and male - specific -
phages due to heterogeneity of
bacterial populations.
In his PhD thesis presented in 1958, Arber showed that in the specialized transducing Lambda
phages several viral genes had been substituted by
bacterial genes for galactose fermentation.
Young's research focuses on
bacterial viruses, also known as bacteriophage or
phage.